Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Current Deferred Revenue (2017 - 2025)

Historic Current Deferred Revenue for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $754000.0.

  • Neuronetics' Current Deferred Revenue fell 4248.67% to $754000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $754000.0, marking a year-over-year decrease of 4248.67%. This contributed to the annual value of $974000.0 for FY2024, which is 3987.65% down from last year.
  • Latest data reveals that Neuronetics reported Current Deferred Revenue of $754000.0 as of Q3 2025, which was down 4248.67% from $894000.0 recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Current Deferred Revenue registered a high of $2.5 million during Q4 2021, and its lowest value of $754000.0 during Q3 2025.
  • Moreover, its 5-year median value for Current Deferred Revenue was $1.7 million (2023), whereas its average is $1.6 million.
  • As far as peak fluctuations go, Neuronetics' Current Deferred Revenue soared by 2381.19% in 2021, and later crashed by 5163.28% in 2025.
  • Neuronetics' Current Deferred Revenue (Quarter) stood at $2.5 million in 2021, then fell by 20.83% to $2.0 million in 2022, then fell by 18.18% to $1.6 million in 2023, then tumbled by 39.88% to $974000.0 in 2024, then fell by 22.59% to $754000.0 in 2025.
  • Its Current Deferred Revenue stands at $754000.0 for Q3 2025, versus $894000.0 for Q2 2025 and $785000.0 for Q1 2025.